Galapagos | GLPG - Current Liabilities

Stock Price
28.90
Daily Change
0.46 1.62%
Monthly
5.86%
Yearly
29.25%
Q1 Forecast
27.75

Galapagos reported EUR366.56M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
argenx SE USD 1.04B 371.99M Jun/2025
AstraZeneca USD 34.05B 518M Sep/2025
Biogen USD 3.29B 106.3M Sep/2025
Genmab DKK 629M 127M Jun/2025
Gilead Sciences USD 12.3B 1.11B Sep/2025
GlaxoSmithKline GBP 21.33B 956M Sep/2025
GRIFOLS EUR 2.15B 164.7M Sep/2025
Hikma Pharmaceutical USD 2.06B 78M Jun/2025
Incyte USD 1.34B 60.11M Sep/2025
Merck EUR 8.64B 1.22B Sep/2025
Neurocrine Biosciences USD 638M 91.7M Sep/2025
Novartis USD 32B 286M Sep/2025
Roche Holding CHF 28B 421M Dec/2025
Sanofi EUR 28.35B 3.76B Dec/2025
UCB EUR 3.53B 731M Dec/2024
Vertex Pharmaceuticals USD 4.48B 336.9M Sep/2025